MXPA02011512A - Carbamatos y carbamidas novedosos, su produccion y uso como antagonistas de los receptores para endotelina. - Google Patents

Carbamatos y carbamidas novedosos, su produccion y uso como antagonistas de los receptores para endotelina.

Info

Publication number
MXPA02011512A
MXPA02011512A MXPA02011512A MXPA02011512A MXPA02011512A MX PA02011512 A MXPA02011512 A MX PA02011512A MX PA02011512 A MXPA02011512 A MX PA02011512A MX PA02011512 A MXPA02011512 A MX PA02011512A MX PA02011512 A MXPA02011512 A MX PA02011512A
Authority
MX
Mexico
Prior art keywords
carbamides
production
receptor antagonists
endothelin receptor
novel carbamates
Prior art date
Application number
MXPA02011512A
Other languages
English (en)
Inventor
Wilhelm Amberg
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of MXPA02011512A publication Critical patent/MXPA02011512A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02011512A 2000-05-25 2001-05-18 Carbamatos y carbamidas novedosos, su produccion y uso como antagonistas de los receptores para endotelina. MXPA02011512A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10025728A DE10025728A1 (de) 2000-05-25 2000-05-25 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten
PCT/EP2001/005742 WO2001090079A2 (de) 2000-05-25 2001-05-18 Neue carbamate und harnstoffe, ihre herstellung und verwendung als endothelin-rezeptorantagonisten

Publications (1)

Publication Number Publication Date
MXPA02011512A true MXPA02011512A (es) 2003-06-30

Family

ID=7643406

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011512A MXPA02011512A (es) 2000-05-25 2001-05-18 Carbamatos y carbamidas novedosos, su produccion y uso como antagonistas de los receptores para endotelina.

Country Status (8)

Country Link
US (1) US20040034076A1 (es)
EP (1) EP1286973A2 (es)
JP (1) JP2003534329A (es)
AU (1) AU2001265995A1 (es)
CA (1) CA2410304A1 (es)
DE (1) DE10025728A1 (es)
MX (1) MXPA02011512A (es)
WO (1) WO2001090079A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329911A1 (de) * 1993-09-04 1995-03-09 Basf Ag Substituierte Milchsäurederivate mit einem N-organischen Rest in beta-Position
DE19614534A1 (de) * 1996-04-12 1997-10-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
WO1999023078A2 (de) * 1997-10-31 1999-05-14 Basf Aktiengesellschaft Neue carbonsäurederivate, die amidseitenketten tragen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten

Also Published As

Publication number Publication date
WO2001090079A3 (de) 2002-04-04
WO2001090079A2 (de) 2001-11-29
DE10025728A1 (de) 2001-11-29
EP1286973A2 (de) 2003-03-05
US20040034076A1 (en) 2004-02-19
CA2410304A1 (en) 2002-11-22
JP2003534329A (ja) 2003-11-18
AU2001265995A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
ZA200104196B (en) Azepinoindole derivatives, the production and use thereof.
PL347500A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
ZA200407794B (en) Novel biomaterials, their preparation and use.
IL163817A0 (en) 2,4-Diaminopyrimidine
MXPA03000738A (es) Antagonistas de grelina.
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
MXPA02007289A (es) Agonistas y antagonistas novedosos de receptores de melanocortina.
AU2003265853A8 (en) Hedgehog antagonists, methods and uses related thereto
MXPA03002907A (es) Antagonistas receptores metabotropicos de glutamato.
PL347885A1 (en) Azepinoindole derivatives, the production and use thereof
IL153789A0 (en) Chemokine receptor modulators, production and use
MXPA03005408A (es) Materiales que tienen memoria de forma.
AU2001295412A1 (en) A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide
HK1042699A1 (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.
FI104003B1 (fi) Stabiloitu täyteaine, sen valmistus ja käyttö
MXPA03003892A (es) Antagonistas del receptor bombesin.
HUP0302208A3 (en) Deltamethrin-containing, water-dispersible granular material, production and use thereof
MXPA03004414A (es) Natagonistas del receptor bombesin.
ZA200201780B (en) Vitronectin receptor antagonists.
MXPA02011512A (es) Carbamatos y carbamidas novedosos, su produccion y uso como antagonistas de los receptores para endotelina.
PL378402A1 (pl) Pirymidyny, sposoby ich wytwarzania i ich zastosowanie
ZA200104138B (en) Moldable abrasive pellets, their production and use.
ZA200400194B (en) Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists.
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
AU2003299336A8 (en) Diphosphines, preparation and uses thereof